Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome

BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor activation delays the progression of diabetic nephropathy (DN) in rodents. The NOD-like receptor 3 (Nlrp3) inflammasome plays an important role in DN. Dipeptidyl peptidase-4 inhibitors (DPP4I) inhibit the degradation of endogenous GLP-1 and variou...

Descripción completa

Detalles Bibliográficos
Autores principales: Birnbaum, Yochai, Bajaj, Mandeep, Qian, Jinqiao, Ye, Yumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985834/
https://www.ncbi.nlm.nih.gov/pubmed/27547413
http://dx.doi.org/10.1136/bmjdrc-2016-000227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985834/
https://www.ncbi.nlm.nih.gov/pubmed/27547413
http://dx.doi.org/10.1136/bmjdrc-2016-000227

Ejemplares similares